The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States
Open accessAbstract
Importance: Treatment with methadone or buprenorphine is the current standard of care for opioid use disorder. Given the paucity of research identifying which patients will respond best to which medication, both medications should be accessible to all patients so that patients can determine which works best for them. However, given differences in the historical contexts of their initial implementation, access to each of these medications may vary along racial/ethnic lines. Objective: To examine the extent to which capacity to provide methadone and buprenorphine vary with measures of racial/ethnic segregation. Design, Setting, and Participants: This cross-sectional study included all counties and county-equivalent divisions in the US in 2016. Data on racial/ethnic population distribution were derived from the American Community Survey, and data on locations of facilities providing methadone and buprenorphine were obtained from Substance Abuse and Mental Health Services Administration databases. Data were analyzed from August 22, 2018, to September 11, 2019. Exposures: Two county-level measures of racial/ethnic segregation, including dissimilarity (representing the proportion of African American or Hispanic/Latino residents who would need to move census tracts to achieve a uniform spatial distribution of the population by race/ethnicity) and interaction (representing the probability that an African American or Hispanic/Latino resident will interact with a white resident and vice versa, assuming random mixing across census tracts). Main Outcomes and Measures: County-level capacity to provide methadone or buprenorphine, defined as the number of facilities providing a medication per 100 000 population. Results: Among 3142 US counties, there were 1698 facilities providing methadone (0.6 facilities per 100 000 population) and 18 868 facilities providing buprenorphine (5.9 facilities per 100 000 population). Each 1% decrease in probability of interaction of an African American resident with a white resident was associated with 0.6 more facilities providing methadone per 100 000 population. Similarly, each 1% decrease in probability of interaction of a Hispanic/Latino resident with a white resident was associated with 0.3 more facilities providing methadone per 100 000 population. Each 1% decrease in the probability of interaction of a white resident with an African American resident was associated with 8.17 more facilities providing buprenorphine per 100 000 population. Similarly, each 1% decrease in the probability of interaction of a white resident with a Hispanic/Latino resident was associated with 1.61 more facilities providing buprenorphine per 100 000 population. Conclusions and Relevance: These findings suggest that the racial/ethnic composition of a community was associated with which medications residents would likely be able to access when seeking treatment for opioid use disorder. Reforms to existing regulations governing the provisions of these medications are needed to ensure that both medications are equally accessible to all.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Interpretation of Statistical Maps
Moran, P. A. P. (1948) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1948.tb00012.x · Cited by 2,882
Increases in drug and opioid-involved overdose deaths – United States, 2010-2015
Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm655051e1 · Cited by 2,194
Increases in drug and opioid overdose deaths — United States, 2000–2014
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6450a3 · Cited by 1,859
2013 NCHS Urban-Rural Classification Scheme for Counties.
Ingram, D. D., & Franco, S. J. (2012) · PubMed · Cited by 1,762
Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm675152e1 · Cited by 1,731
The Modifiable Areal Unit Problem in Multivariate Statistical Analysis
Fotheringham, A. S., & Wong, D. W. S. (1991) · Environment and Planning A: Economy and Space · doi:10.1068/a231025 · Cited by 1,540
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3107 · Cited by 1,076
Comparative effectiveness of different treatment pathways for opioid use disorder.
Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.20622 · Cited by 995
Kampman, K., & Jarvis, M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000166 · Cited by 678
The SAGE Handbook of Spatial Analysis
Fotheringham, A., & Rogerson, P. (2009) · SAGE Publications Ltd eBooks · doi:10.4135/9780857020130 · Cited by 464
Testing for Spatial Autocorrelation Among Regression Residuals
Cliff, A. D., & Ord, K. (1972) · Geographical Analysis · doi:10.1111/j.1538-4632.1972.tb00475.x · Cited by 441
Management of opioid use disorder in the USA: present status and future directions
Blanco, C., & Volkow, N. D. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33078-2 · Cited by 407
Netherland, J., & Hansen, H. B. (2016) · Culture, Medicine, and Psychiatry · doi:10.1007/s11013-016-9496-5 · Cited by 387
Andrilla, C. H. A., Moore, T. E., Patterson, D. G., & Larson, E. H. (2019) · The Journal of Rural Health · doi:10.1111/jrh.12307 · Cited by 311
DOLE, V. P. (1966) · Archives of Internal Medicine · doi:10.1001/archinte.1966.00290160004002 · Cited by 290
Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States
Chen, Q., Larochelle, M. R., Weaver, D. T., Lietz, A. P., Mueller, P. P., Mercaldo, S., Wakeman, S. E., Freedberg, K. A., Raphel, T. J., Knudsen, A. B., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7621 · Cited by 274
A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.13 · Cited by 260
Successful Treatment of 750 Criminal Addicts
Dole, V. P. (1968) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1968.03150120042009 · Cited by 254
Residential Segregation and Disparities in Health Care Services Utilization
Gaskin, D. J., Dinwiddie, G. Y., Chan, K. S., & McCleary, R. (2012) · Medical Care Research and Review · doi:10.1177/1077558711420263 · Cited by 247
Hansen, H. B., Siegel, C. E., Case, B. G., Bertollo, D. N., DiRocco, D., & Galanter, M. (2013) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-013-9341-3 · Cited by 225
Hser, Y., Evans, E., Huang, D., Weiss, R., Saxon, A., Carroll, K. M., Woody, G., Liu, D., Wakim, P., Matthews, A. G., et al. (2016) · Addiction · doi:10.1111/add.13238 · Cited by 221
Is the Prescription Opioid Epidemic a White Problem?
Hansen, H., & Netherland, J. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303483 · Cited by 207
Methadone as Social Control: Institutionalized Stigma and the Prospect of Recovery
Harris, J., & McElrath, K. (2012) · Qualitative Health Research · doi:10.1177/1049732311432718 · Cited by 201
Federal Regulation of Methadone Treatment
Rettig, R. A., & Yarmolinsky, A. (2013) · Cited by 165
Update on Barriers to Pharmacotherapy for Opioid Use Disorders
Sharma, A., Kelly, S. M., Mitchell, S. G., Gryczynski, J., O’Grady, K. E., & Schwartz, R. P. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0783-9 · Cited by 163
Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver
Fiscella, K., Wakeman, S. E., & Beletsky, L. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3685 · Cited by 158
Changes in Methadone Treatment Practices: Results From a National Panel Study, 1988-2000
D’Aunno, T. A., & Pollack, H. A. (2002) · JAMA · doi:10.1001/jama.288.7.850 · Cited by 148
Why buprenorphine is so successful in treating opiate addiction in France
Fatseas, M., & Auriacombe, M. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0046-2 · Cited by 144
Stein, B. D., Dick, A. W., Sorbero, M., Gordon, A. J., Burns, R. M., LESLIE, D. L., & Pacula, R. L. (2018) · Substance Abuse · doi:10.1080/08897077.2018.1449166 · Cited by 131
Methadone Matters: What the United States Can Learn from the Global Effort to Treat Opioid Addiction
Calcaterra, S., Bach, P., Chadi, A., Chadi, N., Kimmel, S. D., Morford, K. L., Roy, P., & Samet, J. H. (2019) · Journal of general internal medicine · doi:10.1007/s11606-018-4801-3 · Cited by 119
Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966) · PubMed · Cited by 103
On federal regulation of methadone treatment
Dole, V. P. (1995) · JAMA · doi:10.1001/jama.274.16.1307 · Cited by 93
Hansen, H., & Roberts, S. (2012) · Advances in medical sociology · doi:10.1108/s1057-6290(2012)0000014008 · Cited by 91
Positional accuracy and geographic bias of four methods of geocoding in epidemiologic research.
Schootman, M., Sterling, D., Struthers, J., Yan, Y., Laboube, T., Emo, B., & Higgs, G. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2006.10.015 · Cited by 80
Changes in Methadone Treatment Practices: Results from a Panel Study, 1988–1995
D’Aunno, T. A., Folz-Murphy, N., & Lin, X. (1999) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100101886 · Cited by 72
Narcotic blockade--a medical technique for stopping heroin use by addicts.
Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966) · PubMed · Cited by 65
Manhapra, A., Quinones, L., & Rosenheck, R. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.035 · Cited by 64
Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012–2014
Chatterjee, A., Larochelle, M. R., Xuan, Z., Wang, N., Bernson, D., Silverstein, M., Hadland, S. E., Land, T. G., Samet, J. H., Walley, A. Y., et al. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.09.020 · Cited by 40
Self-citationMethadone and Chemotherapy in Drug Addiction
Chappel, J. N. (1974) · JAMA · doi:10.1001/jama.1974.03230310035024 · Cited by 8
Cited by
Thompson, H. M., Sharma, B., Bhalla, S., Boley, R., McCluskey, C., Dligach, D., Churpek, M. M., Karnik, N. S., & Afshar, M. (2021) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocab148 · Cited by 78
Projected estimates of opioid mortality after community-level interventions.
Linas, B. P., Savinkina, A., Madushani, R. W. M. A., Wang, J., Eftekhari Yazdi, G., Chatterjee, A., Walley, A. Y., Morgan, J. R., Epstein, R. L., Assoumou, S. A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.37259 · Cited by 72
Krawczyk, N., Rivera, B. D., Chang, J. E., Grivel, M., Chen, Y.-H., Nagappala, S., Englander, H., & McNeely, J. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00422-w · Cited by 28
Metadata
- Authors
- Goedel, W. C., Shapiro, A., Cerdá, M., Tsai, J. W., Hadland, S. E., & Marshall, B. D. L.
- Venue
- JAMA Network Open
- Publisher
- American Medical Association (AMA)
- Published
- 2020-04-22
- Volume
- 3
- Issue
- 4
- Pages
- e203711
- ISSN
- 2574-3805 (ISSN-L)
- OpenAlex
- W3016631191
- Cited by
- 295
- References
- 41
- FWCI
- 29.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.